Advertisement

Comparison of four sarcopenia screening tools in nursing home residents

  • Ming Yang
  • Jing Lu
  • Jiaojiao Jiang
  • Yanli Zeng
  • Huairong TangEmail author
Original Article

Abstract

Background

Several screening tools have been developed for identifying sarcopenia in elderly nursing home residents.

Objective

To compare the diagnostic accuracy of four sarcopenia screening tools in nursing homes: Mini Sarcopenia Risk Assessment full version (MSRA-7) and short version (MSRA-5), SARC-F, and SARC-F combined with calf circumference (SARC-CalF).

Methods

Elderly nursing home residents (aged ≥ 65 years) were recruited. Four common diagnostic criteria (EWGSOP, AWGS, IWGS, and FNIH) were separately applied as the “gold standard”. The sensitivity/specificity analyses of the four tools were calculated. Receiver operating characteristic (ROC) curves and area under the ROC curves (AUC) were applied to compare the overall diagnostic accuracy.

Results

We included 277 participants aged 81.6 ± 3.3 years. Using different “gold standards”, the sensitivity of SARC-CalF, SARC-F, MSRA-7, and MSRA-5 ranged from 55.7 to 64.4%, from 17.0 to 21.8%, from 53.3 to 57.8%, and from 49.1 to 56.7%, respectively, whereas the specificity ranged from 84.5 to 86.5%, from 96.8 to 98.4%, from 80.2 to 84.2%, and from 82.8 to 84.1%, respectively. Regardless of the “gold standard”, SARC-CalF had the largest AUC (from 0.816 to 0.867) among the tools; the AUC of SARC-F (from 0.769 to 0.791) and MSRA-5 (from 0.713 to 0.767) was not significantly different; whereas MSRA-7 had the smallest AUC (from 0.681 to 0.746).

Conclusion

Among the four screening tools, SARC-CalF appears to be an optimal choice for screening sarcopenia in nursing home residents. SARC-F and MSRA-5 are alternatives, of which, SARC-F has a better specificity and MSRA-5 has a better sensitivity.

Keywords

Sarcopenia Nursing home Screening Specificity Sensitivity 

Notes

Funding

This study was supported by the Health and Family Planning Commission of Sichuan Province (No. ZH2018-102 and No. 2018-116). The sponsor had no role in the design, methods, data collection, analysis or preparation of this manuscript.

Compliance with ethical standards

Conflict of interest

All authors have no conflict of interest to declare.

Human and animal rights

All procedures performed in this study involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. This article does not contain any study with animals performed by any of the authors.

Informed consent

Informed consent was obtained from all the participants in this study or their legal proxies.

Supplementary material

40520_2018_1083_MOESM1_ESM.pdf (151 kb)
Supplementary material 1 (PDF 150 KB)
40520_2018_1083_MOESM2_ESM.pdf (167 kb)
Supplementary material 2 (PDF 166 KB)

References

  1. 1.
    Senior HE, Henwood TR, Beller EM et al (2015) Prevalence and risk factors of sarcopenia among adults living in nursing homes. Maturitas 82:418–423CrossRefGoogle Scholar
  2. 2.
    Landi F, Liperoti R, Fusco D et al (2012) Sarcopenia and mortality among older nursing home residents. J Am Med Dir Assoc 13:121–126CrossRefGoogle Scholar
  3. 3.
    Cruz-Jentoft AJ, Landi F, Schneider SM et al (2014) Prevalence of and interventions for sarcopenia in ageing adults: a systematic review. Report of the International Sarcopenia Initiative (EWGSOP and IWGS). Age Ageing 43:748–759CrossRefGoogle Scholar
  4. 4.
    Anker SD, Morley JE, von Haehling S (2016) Welcome to the ICD-10 code for sarcopenia. J Caxhexia Sarcopenia Muscle 7:512–514CrossRefGoogle Scholar
  5. 5.
    Falcon LJ, Harris-Love MO (2017) Sarcopenia and the new ICD-10-CM code: screening, staging, and diagnosis considerations. Fed Pract 34:24–32PubMedPubMedCentralGoogle Scholar
  6. 6.
    Cruz-Jentoft AJ, Baeyens JP, Bauer JM et al (2010) Sarcopenia: European consensus on definition and diagnosis: report of the European Working Group on Sarcopenia in Older People. Age Ageing 39:412–423CrossRefGoogle Scholar
  7. 7.
    Chen LK, Liu LK, Woo J et al (2014) Sarcopenia in Asia: consensus report of the asian working group for sarcopenia. J Am Med Dir Assoc 15:95–101CrossRefGoogle Scholar
  8. 8.
    Fielding RA, Vellas B, Evans WJ et al (2011) Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences. International working group on sarcopenia. J Am Med Dir Assoc 12:249–256CrossRefGoogle Scholar
  9. 9.
    Studenski SA, Peters KW, Alley DE et al (2014) The FNIH Sarcopenia Project: rationale, study description, conference recommendations, and final estimates. J Gerontol Ser A Biol Sci Med Sci 69:547–558CrossRefGoogle Scholar
  10. 10.
    Malmstrom TK, Morley JE (2013) SARC-F: a simple questionnaire to rapidly diagnose sarcopenia. J Am Med Dir Assoc 14:531–532CrossRefGoogle Scholar
  11. 11.
    Ida S, Kaneko R, Murata K (2018) SARC-F for screening of sarcopenia among older adults: a meta-analysis of screening test accuracy. J Am Med Dir Assoc 19:685–689CrossRefGoogle Scholar
  12. 12.
    Malmstrom TK, Miller DK, Simonsick EM et al (2016) SARC-F: a symptom score to predict persons with sarcopenia at risk for poor functional outcomes. J Cachexia Sarcopenia Muscle 7:28–36CrossRefGoogle Scholar
  13. 13.
    Woo J, Leung J, Morley JE (2014) Validating the SARC-F: a suitable community screening tool for sarcopenia? J Am Med Dir Assoc 15:630–634CrossRefGoogle Scholar
  14. 14.
    Ida S, Murata K, Nakadachi D et al (2017) Development of a Japanese version of the SARC-F for diabetic patients: an examination of reliability and validity. Aging Clin Exp Res 29:935–942CrossRefGoogle Scholar
  15. 15.
    Kim S, Kim M, Won CW (2018) Validation of the Korean version of the SARC-F questionnaire to assess sarcopenia: Korean frailty and aging cohort study. J Am Med Dir Assoc 19:40–45CrossRefGoogle Scholar
  16. 16.
    Beaudart C, Locquet M, Bornheim S et al (2018) French translation and validation of the sarcopenia screening tool SARC-F. Eur Geriatr Med 9:29–37CrossRefGoogle Scholar
  17. 17.
    Parra-Rodriguez L, Szlejf C, Garcia-Gonzalez AI et al (2016) Cross-cultural adaptation and validation of the Spanish-language version of the SARC-F to assess sarcopenia in Mexican community-dwelling older adults. J Am Med Dir Assoc 17:1142–1146CrossRefGoogle Scholar
  18. 18.
    Barbosa-Silva TG, Menezes AM, Bielemann RM et al (2016) Grupo de Estudos em Composicao Corporal e N. Enhancing SARC-F: improving sarcopenia screening in the clinical practice. J Am Med Dir Assoc 17:1136–1141CrossRefGoogle Scholar
  19. 19.
    Yang M, Hu X, Xie L et al (2018) Screening sarcopenia in community-dwelling older adults: SARC-F vs SARC-F combined with calf circumference (SARC-CalF). J Am Med Dir Assoc 19:277.e1–277.e8CrossRefGoogle Scholar
  20. 20.
    Rossi AP, Micciolo R, Rubele S et al (2017) Assessing the risk of sarcopenia in the elderly: the mini sarcopenia risk assessment (MSRA) questionnaire. J Nutr Health Aging 21:743–749CrossRefGoogle Scholar
  21. 21.
    Yang M, Hu X, Xie L et al (2018) Comparing mini sarcopenia risk assessment with SARC-F for screening sarcopenia in community-dwelling older adults. J Am Med Dir Assoc.  https://doi.org/10.1016/j.jamda.2018.04.012 CrossRefPubMedGoogle Scholar
  22. 22.
    Quan H, Li B, Couris CM et al (2011) Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries. Am J Epidemiol 173:676–682CrossRefGoogle Scholar
  23. 23.
    Kaiser MJ, Bauer JM, Ramsch C et al (2009) Validation of the mini nutritional assessment short-form (MNA-SF): a practical tool for identification of nutritional status. J Nutr Health Aging 13:782–788CrossRefGoogle Scholar
  24. 24.
    Jaeschke R, Guyatt GH, Sackett DL (1994) Users’ guides to the medical literature. III. How to use an article about a diagnostic test. B. What are the results and will they help me in caring for my patients? The Evidence-Based Medicine Working Group. JAMA 271:703–707CrossRefGoogle Scholar
  25. 25.
    Lalkhen AG, McCluskey A (2008) Clinical tests: sensitivity and specificity. Contin Educ Anaesth Crit Care Pain 8:221–223CrossRefGoogle Scholar
  26. 26.
    DeLong ER, DeLong DM, Clarke-Pearson DL (1988) Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 44:837–845CrossRefGoogle Scholar
  27. 27.
    Linden A (2006) Measuring diagnostic and predictive accuracy in disease management: an introduction to receiver operating characteristic (ROC) analysis. J Eval Clin Pract 12:132–139CrossRefGoogle Scholar
  28. 28.
    Urzi F, Šimunič B, Buzan E (2017) Basis for sarcopenia screening with the SARC-CalF in nursing homes. J Am Med Dir Assoc 18:991.e5–991.e10CrossRefGoogle Scholar
  29. 29.
    Kawakami R, Murakami H, Sanada K et al (2015) Calf circumference as a surrogate marker of muscle mass for diagnosing sarcopenia in Japanese men and women. Geriatr Gerontol Int 15:969–976CrossRefGoogle Scholar
  30. 30.
    Bahat G, Tufan A, Tufan F et al (2016) Cut-off points to identify sarcopenia according to European Working Group on Sarcopenia in Older People (EWGSOP) definition. Clin Nutr 35:1557–1563CrossRefGoogle Scholar
  31. 31.
    Hwang AC, Liu LK, Lee WJ et al (2018) Calf circumference as a screening instrument for appendicular muscle mass measurement. J Am Med Dir Assoc 19:182–184CrossRefGoogle Scholar
  32. 32.
    Locquet M, Beaudart C, Reginster JY et al (2018) Comparison of the performance of five screening methods for sarcopenia. Clin Epidemiol 10:71–82CrossRefGoogle Scholar
  33. 33.
    Goodman MJ, Ghate SR, Mavros P et al (2013) Development of a practical screening tool to predict low muscle mass using NHANES 1999–2004. J Cachexia Sarcopenia Muscle 4:187–197CrossRefGoogle Scholar
  34. 34.
    Ishii S, Tanaka T, Shibasaki K et al (2014) Development of a simple screening test for sarcopenia in older adults. Geriatr Gerontol Int 14:93–101CrossRefGoogle Scholar
  35. 35.
    Yu S, Appleton S, Chapman I et al (2015) An anthropometric prediction equation for appendicular skeletal muscle mass in combination with a measure of muscle function to screen for sarcopenia in primary and aged care. J Am Med Dir Assoc 16:25–30CrossRefGoogle Scholar
  36. 36.
    Sallin U, Mellstrom D, Eggertsen R (2005) Osteoporosis in a nursing home, determined by the DEXA technique. Med Sci Monit 11:CR67–C70PubMedGoogle Scholar
  37. 37.
    Zeng Y, Hu X, Xie L et al (2018) The prevalence of sarcopenia in Chinese elderly nursing home residents: a comparison of 4 diagnostic criteria. J Am Med Dir Assoc 19:690–695CrossRefGoogle Scholar
  38. 38.
    Hassan EB, Duque G. Osteosarcopenia (2017) A new geriatric syndrome. Aust Fam Phys 46:849–853Google Scholar
  39. 39.
    Yu R, Leung J, Woo J (2014) Sarcopenia combined with FRAX probabilities improves fracture risk prediction in older Chinese men. J Am Med Dir Assoc 15:918–923CrossRefGoogle Scholar
  40. 40.
    Cruz-Jentoft AJ, Bahat G, Bauer J et al (2018) Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing.  https://doi.org/10.1093/ageing/afy169 CrossRefPubMedGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2018

Authors and Affiliations

  1. 1.The Center of Gerontology and Geriatrics, West China HospitalSichuan UniversityChengduChina
  2. 2.Precision Medicine Research Center, West China HospitalSichuan UniversityChengduChina
  3. 3.Department of Pharmacy, West China HospitalSichuan UniversityChengduChina
  4. 4.The Center of Rehabilitation, West China HospitalSichuan UniversityChengduChina
  5. 5.Institute for Disaster Management and ReconstructionSichuan UniversityChengduChina
  6. 6.School of NursingChengdu University of Traditional Chinese MedicineChengduChina
  7. 7.Health Management Center, West China HospitalSichuan UniversityChengduChina

Personalised recommendations